Clinical Trial Detail

NCT ID NCT01690624
Title BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients in Complete Remission With High Risk to Relapse
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

acute myeloid leukemia

Therapies

BI 836858

Age Groups: adult senior

No variant requirements are available.